<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38252638</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Characteristics and burden of acute COVID-19 and long-COVID: Demographic, physical, mental health, and economic perspectives.</ArticleTitle><Pagination><StartPage>e0297207</StartPage><MedlinePgn>e0297207</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0297207</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0297207</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19 infection and its associated consequence, known as long-COVID, lead to a significant burden on the global healthcare system and limitations in people's personal and work lives. This study aims to provide further insight into the impact of acute and ongoing COVID-19 symptoms and investigates the role of patients' gender and vaccination status.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">416 individuals (73.9% female) between the ages of 16 and 80 years (M = 44.18, SD = 12.90) with self-reported symptoms of long-COVID participated in an online survey conducted between March and May 2022.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">6.0%, 74.3%, and 19.7% of all respondents reported having had an asymptomatic, mild, or severe acute illness, respectively. Out of all participants, 7.8% required hospitalization. The most prevalent symptoms during the acute infection (Mdn = 23.50 symptoms, IQR = 13-39) included fatigue, exhaustion, cough, brain fog, and memory problems. The median long-COVID disease duration was 12.10 months (IQR = 2.8-17.4). Among 64 inquired long-COVID symptoms (Mdn = 17.00 symptoms, IQR = 9-27), participants reported fatigue, exhaustion, memory problems, brain fog, and dyspnea as the most common ongoing symptoms, which were generally experienced as fluctuating and deteriorating after physical or cognitive activity. Common consequences of long-COVID included financial losses (40.5%), changes in the participants' profession (41.0%), stress resistance (87.5%), sexual life (38.1%), and mood (72.1%), as well as breathing difficulties (41.3%), or an increased drug intake (e.g., medicine, alcohol; 44.6%). In addition, vaccinated individuals exhibited a shorter acute illness duration and an earlier onset of long-COVID symptoms. In general, women reported more long-COVID symptoms than men.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Long-COVID represents a heterogeneous disease and impacts multiple life aspects of those affected. Tailored rehabilitation programs targeting the plurality of physical and mental symptoms are needed.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Leitner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leitner</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5267-1103</Identifier><AffiliationInfo><Affiliation>Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xf6;tz</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>digitAAL Life GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fellner</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>digitAAL Life GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spat</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>digitAAL Life GmbH, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koini</LastName><ForeName>Marisa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1756-1379</Identifier><AffiliationInfo><Affiliation>Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005222" MajorTopicYN="N">Mental Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38252638</ArticleId><ArticleId IdType="pmc">PMC10802963</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0297207</ArticleId><ArticleId IdType="pii">PONE-D-23-25386</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization: WHO COVID-19 Dashboard. 2022.  [cited April 4, 2023]. Available from: https://covid19.who.int</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020;323(13):1236&#x2013;1242. doi: 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzenschlager S, Zimmer AJ, Gottschalk C, Grafeneder J, Schmitz S, Kraker S, et al.. Can we predict the severe course of COVID-19&#x2014;a systematic review and meta-analysis of indicators of clinical outcome?. PLOS ONE. 2021;16(7):e0255154. doi: 10.1371/journal.pone.0255154</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255154</ArticleId><ArticleId IdType="pmc">PMC8321230</ArticleId><ArticleId IdType="pubmed">34324560</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al.. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. Journal of Clinical Medicine. 2020;9(4):941. doi: 10.3390/jcm9040941</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9040941</ArticleId><ArticleId IdType="pmc">PMC7230636</ArticleId><ArticleId IdType="pubmed">32235486</ArticleId></ArticleIdList></Reference><Reference><Citation>Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. Journal of Preventive Medicine and Hygiene. 2020;61(3):E304&#x2013;E312. doi: 10.15167/2421-4248/jpmh2020.61.3.1530</Citation><ArticleIdList><ArticleId IdType="doi">10.15167/2421-4248/jpmh2020.61.3.1530</ArticleId><ArticleId IdType="pmc">PMC7595075</ArticleId><ArticleId IdType="pubmed">33150219</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslam A, Thibault O, Prasad V. The definition of long COVID used in interventional studies. European Journal of Clinical Investigation. 2023;53(8). doi: 10.1111/eci.13989</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13989</ArticleId><ArticleId IdType="pubmed">36964995</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, B&#xf6;ing S, Brinkmann F, et al.. S1-Leitlinie Post-COVID/Long-COVID. Pneumologie. 2021;75(11):869&#x2013;900. doi: 10.1055/a-1551-9734</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9734</ArticleId><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ora J, Calzetta L, Frugoni C, Puxeddu E, Rogliani P. Expert Guidance on the Management and Challenges of Long-COVID Syndrome: A Systematic review. Expert Opinion on Pharmacotherapy. 2023;24(3):315&#x2013;30. doi: 10.1080/14656566.2022.2161365</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2022.2161365</ArticleId><ArticleId IdType="pubmed">36542805</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2022 National Institute for Health and Care Excellence (NICE) [cited November 16, 2023]. Available from: https://www.nice.org.uk/guidance/ng188/resources</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive Impairment After COVID-19&#x2014;A Review on Objective Test Data. Frontiers in Neurology. 2021;(12):1&#x2013;9. doi: 10.3389/fneur.2021.699582</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, Hastie C, Roderick P, Yao G, et al.. Characteristics and impact of Long Covid: Findings from an online survey. Sutcliffe CG, editor. PLOS ONE. 2022;17(3):e0264331. doi: 10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken PA, Scherag A, Stallmach A. Postcoronavirus Disease Chronic Fatigue Is Frequent and Not Only Restricted to Hospitalized Patients. Critical Care Medicine. 2021;49(10):e1052&#x2013;3. doi: 10.1097/CCM.0000000000005122</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005122</ArticleId><ArticleId IdType="pmc">PMC8439636</ArticleId><ArticleId IdType="pubmed">34034301</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al.. Symptoms and risk factors for long COVID in non-hospitalized adults. Nature Medicine. 2022;28(8):1706&#x2013;14. doi: 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al.. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al.. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. eClinicalMedicine. 2022;(53):1&#x2013;19. doi: 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Vimercati L, De Maria L, Quarato M, Caputi A, Gesualdo L, Migliore G, et al.. Association between Long COVID and Overweight/Obesity. Journal of Clinical Medicine. 2021;10(18):4143. doi: 10.3390/jcm10184143</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184143</ArticleId><ArticleId IdType="pmc">PMC8469321</ArticleId><ArticleId IdType="pubmed">34575251</ArticleId></ArticleIdList></Reference><Reference><Citation>Caz&#xe9; AB, Cerqueira&#x2010;Silva T, Bomfim AP, De Souza GL, Azevedo ACAC, Brasil MQ, et al.. Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group. Journal of Global Health. 2023;13. doi: 10.7189/jogh.13.06015</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.06015</ArticleId><ArticleId IdType="pmc">PMC10173895</ArticleId><ArticleId IdType="pubmed">37166260</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID&#x2010;19: A systematic review. International Journal of Clinical Practice. 2021;75(10):e14357. doi: 10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh V. Impacts of COVID-19: A research agenda to support people in their fight. International Journal of Information Management. 2020;(55):102197. doi: 10.1016/j.ijinfomgt.2020.102197</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijinfomgt.2020.102197</ArticleId><ArticleId IdType="pmc">PMC7368151</ArticleId><ArticleId IdType="pubmed">32836648</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;(38):101019. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhan R, Agrawal A, Sharma M. Prevalence of depression, anxiety, and stress during COVID-19 pandemic. Journal of Neurosciences in Rural Practice. 2020;11(4):519&#x2013;525. doi: 10.1055/s-0040-1716442</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1716442</ArticleId><ArticleId IdType="pmc">PMC7595780</ArticleId><ArticleId IdType="pubmed">33144785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: Evidence of mood &amp; cognitive impairment. Brain, Behavior, &amp; Immunity&#x2013;Health. 2021;(17):100347. doi: 10.1016/j.bbih.2021.100347</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100347</ArticleId><ArticleId IdType="pmc">PMC8437695</ArticleId><ArticleId IdType="pubmed">34549199</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudenstine S, Schulder T, Bhatt KJ, McNeal K, Ettman CK, Galea S. Long-COVID and comorbid depression and anxiety two years into the COVID-19 pandemic. Psychiatry Research. 2022;(317):114924. doi: 10.1016/j.psychres.2022.114924</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114924</ArticleId><ArticleId IdType="pmc">PMC9597528</ArticleId><ArticleId IdType="pubmed">37732865</ArticleId></ArticleIdList></Reference><Reference><Citation>Harirugsakul K, Wainipitapong S, Phannajit J, Paitoonpong L, Tantiwongse K. Erectile dysfunction after COVID-19 recovery: A follow-up study. Kim T, editor. PLOS ONE. 2022;17(10):e0276429. doi: 10.1371/journal.pone.0276429</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276429</ArticleId><ArticleId IdType="pmc">PMC9584530</ArticleId><ArticleId IdType="pubmed">36264947</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi&#x2010;Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al.. Long COVID syndrome&#x2010;associated brain fog. Journal of Medical Virology. 2021;94(3). doi: 10.1002/jmv.27404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawilska JB, Kuczy&#x144;ska K. Psychiatric and neurological complications of long COVID. Journal of Psychiatric Research. 2022;(156):349&#x2013;360. doi: 10.1016/j.jpsychires.2022.10.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.10.045</ArticleId><ArticleId IdType="pmc">PMC9582925</ArticleId><ArticleId IdType="pubmed">36326545</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Limoncin E, Ciocca G, B&#x1eaf;c NH, Cao TN, et al.. The Sexual Long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 long haulers. Sexual Medicine Reviews. 2021;10(2):271&#x2013;285. doi: 10.1016/j.sxmr.2021.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sxmr.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8604714</ArticleId><ArticleId IdType="pubmed">34933829</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs. 2022;36(7):681&#x2013;702. doi: 10.1007/s40263-022-00931-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al.. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. The Lancet. 2022;399(10335):1618&#x2013;1624. doi: 10.1016/S0140-6736(22)00327-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al.. COVID&#x2010;19 diagnosis and management: a comprehensive review. Journal of Internal Medicine. 2020;288(2):157&#x2013;265. doi: 10.1111/joim.13091</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13091</ArticleId><ArticleId IdType="pmc">PMC7267177</ArticleId><ArticleId IdType="pubmed">32348588</ArticleId></ArticleIdList></Reference><Reference><Citation>Unim B, Palmieri L, Lo Noce C, Brusaferro S, Onder G. Prevalence of COVID-19-related symptoms by age group. Aging Clinical and Experimental Research. 2021;33(4):1145&#x2013;7. doi: 10.1007/s40520-021-01809-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01809-y</ArticleId><ArticleId IdType="pmc">PMC7919615</ArticleId><ArticleId IdType="pubmed">33650071</ArticleId></ArticleIdList></Reference><Reference><Citation>Peres KC, Riera R, Martimbianco ALC, Ward LS, Cunha LL. Body Mass Index and Prognosis of COVID-19 Infection. A Systematic Review. Frontiers in Endocrinology. 2020;(11):1&#x2013;10. doi: 10.3389/fendo.2020.00562</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00562</ArticleId><ArticleId IdType="pmc">PMC7456965</ArticleId><ArticleId IdType="pubmed">32922366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok S, Adam S, Ho JH, Iqbal Z, Turkington P, Razvi S, et al.. Obesity: A critical risk factor in the COVID &#x2010;19 pandemic. Clinical Obesity. 2020;10(6):e12403. doi: 10.1111/cob.12403</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cob.12403</ArticleId><ArticleId IdType="pmc">PMC7460880</ArticleId><ArticleId IdType="pubmed">32857454</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez JMD, Du-Fay-de-Lavallaz JM, Fugar S, Sarau A, Simmons JA, Clark B, et al.. Sex Differences in Coronavirus Disease 2019 (COVID-19) Hospitalization and Mortality. Journal of Women&#x2019;s Health. 2021;30(5):646&#x2013;653. doi: 10.1089/jwh.2020.8948</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2020.8948</ArticleId><ArticleId IdType="pubmed">33826864</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al.. Persistent neurologic symptoms and cognitive dysfunction in non&#x2010;hospitalized Covid&#x2010;19 &#x201c;long haulers.&#x201d; Annals of Clinical and Translational Neurology. 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, Valles-Salgado M, Delgado-&#xc1;lvarez A, Yus M, G&#xf3;mez-Ruiz N, Jorquera M, et al.. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. Journal of Psychiatric Research. 2022;(150):40&#x2013;46. doi: 10.1016/j.jpsychires.2022.03.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bautista-Rodriguez E, Cort&#xe9;s-&#xc1;lvarez NY, Vuelvas-Olmos CR, Reyes-Meza V, Gonz&#xe1;lez-L&#xf3;pez T, Flores-delos&#xc1;ngeles C, et al.. Stress, anxiety, depression and long COVID symptoms. Fatigue: Biomedicine, Health &amp; Behavior. 2022;11(1):35&#x2013;54. doi: 10.1080/21641846.2022.2154500</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2022.2154500</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahriani M, Ilmawan M, Fajar JK, Maliga HA, Frediansyah A, Masyeni S, et al.. Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis&#x2014;A systematic review and meta-analysis. Narra J. 2021;1(2):e36. doi: 10.52225/narraj.v1i2.36</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narraj.v1i2.36</ArticleId><ArticleId IdType="pmc">PMC10914031</ArticleId><ArticleId IdType="pubmed">38449463</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock MD, Chew R, Preiss A, Hadley E, Redfield S, McMurry JA, et al.. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nature Communications. 2023;14(1). doi: 10.1038/s41467-023-38388-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, M L. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022;19(19):12422. doi: 10.3390/ijerph191912422</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine. 2023;2(1):e000385. doi: 10.1136/bmjmed-2022-000385</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al.. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;(377):e069676. doi: 10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen A, Castro AW, Feretti MT, Martinkova J, Vasilevskaya A, Chadha AS, et al.. Sex and gender differences in the neurological and neuropsychiatric symptoms of long COVID: a narrative review. Italian Journal of Gender-Specific Medicine. 2022;8(1):18&#x2013;28. doi: 10.1723/3769.37563</Citation><ArticleIdList><ArticleId IdType="doi">10.1723/3769.37563</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Wills MR, Sithole N. Long COVID: what is known and what gaps need to be addressed. British Medical Bulletin. 2023;147(1):6&#x2013;19. doi: 10.1093/bmb/ldad016</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldad016</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al.. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. The European Respiratory Journal. 2020;56(1):2001494. doi: 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Flachenecker P, Mei&#xdf;ner H. Fatigue bei Multipler Sklerose&#x2013;wie diagnostizieren, wie behandeln?. Neurologie &amp; Rehabilitation. 2014;20(5):273&#x2013;281.</Citation></Reference><Reference><Citation>Neill J, Belan I, Ried K. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. Journal of Advanced Nursing. 2006;56(6):617&#x2013;35. doi: 10.1111/j.1365-2648.2006.04054.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2648.2006.04054.x</ArticleId><ArticleId IdType="pubmed">17118041</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AM, Safari R, Mercer T, Picariello F, van der Linden ML, White C, et al.. Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis. Multiple Sclerosis Journal. 2021;27(11):1657&#x2013;1678. doi: 10.1177/1352458521996002</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458521996002</ArticleId><ArticleId IdType="pmc">PMC8474304</ArticleId><ArticleId IdType="pubmed">33876986</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman P, Kappos L, Gensicke H, D&#x2019;Souza M, Mohr DC, Penner IK, et al.. MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology. 2010;75(13):1141&#x2013;1149. doi: 10.1212/WNL.0b013e3181f4d80d</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181f4d80d</ArticleId><ArticleId IdType="pmc">PMC3463050</ArticleId><ArticleId IdType="pubmed">20876468</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayapo&#x11f;lu N, Tan M. Evaluation of the Effect of Progressive Relaxation Exercises on Fatigue and Sleep Quality in Patients with Multiple Sclerosis. The Journal of Alternative and Complementary Medicine. 2012;18(10):983&#x2013;987. doi: 10.1089/acm.2011.0390</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2011.0390</ArticleId><ArticleId IdType="pmc">PMC3469207</ArticleId><ArticleId IdType="pubmed">22967281</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A, et al.. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. Di Gennaro F, editor. PLOS ONE. 2021;16(2):e0246590. doi: 10.1371/journal.pone.0246590</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistarini C, Fiabane E, Houdayer E, Vassallo C, Manera MR, Alemanno F. Cognitive and Emotional Disturbances Due to COVID-19: An Exploratory Study in the Rehabilitation Setting. Frontiers in Neurology. 2021;(12):1&#x2013;8. doi: 10.3389/fneur.2021.643646</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.643646</ArticleId><ArticleId IdType="pmc">PMC8165252</ArticleId><ArticleId IdType="pubmed">34079511</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>